Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis

Thanaa Fathi Moghazy; Moyassar Ahmad Zaki; Noha Said Kandil; Dalia Aly Maharem; Khaled Aly Matrawy; Moataz Ahmad Zaki; Alaa Mohamed Ismail El-Banna

doi:10.1080/20905068.2019.1592930

Q3 2019

Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis

Thanaa Fathi Moghazy · Moyassar Ahmad Zaki · Noha Said Kandil · Dalia Aly Maharem · Khaled Aly Matrawy · Moataz Ahmad Zaki · Alaa Mohamed Ismail El-Banna

10.1080/20905068.2019.1592930 392 Views 1 Citations

Citations

392

Views

Abstract not available for this publication.

Cite this Article (APA)

Thanaa, F. M., Moyassar, A. Z., Noha, S. K., Dalia, A. M., Khaled, A. M., Moataz, A. Z., Alaa, M. I. E. (2019). Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis. Alexandria Journal of Medicine. https://doi.org/10.1080/20905068.2019.1592930